Documentos relacionados

1. A pilot study to investigate the associations of urinary concentrations of NO, ATP and derivatives with overactive bladder symptom severity.
2. The use of urinary biomarkers in the diagnosis of overactive bladder in female patients. A systematic review and meta-analysis.
3. Transient receptor potential vanilloid type 4 (TRPV4) in urinary bladder structure and function.
4. KPR-5714, a selective transient receptor potential melastatin 8 antagonist, improves voiding dysfunction in rats with bladder overactivity but does not affect voiding behavior in normal rats.
5. Re: Sheng W, Zhang H, Kirschner-Hermanns R. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis. Neurourol Urodyn. 2017;9999:1-8. doi: 10.1002/nau.23210.
6. Urinary metabolomics predict the severity of overactive bladder syndrome in an aging female population.
7. Performance of urinary biomarkers in differentiating dysfunctional voiding in women with overactive bladder syndrome: a prospective pilot study.
8. Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.
9. Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis/bladder pain syndrome.
10. [Urinary prostaglandins E2 correlates to overactive bladder symptoms in patients with benign prostatic hyperplasia].